These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2456334)

  • 41. Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase.
    Laroche D; Vergnaud MC; Sillard B; Soufarapis H; Bricard H
    Anesthesiology; 1991 Dec; 75(6):945-9. PubMed ID: 1741515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased tryptase levels in suction-blister fluid from patients with urticaria.
    Deleuran B; Kristensen M; Larsen CG; Matsson P; Enander I; Andersson AS; Thestrup-Pedersen K
    Br J Dermatol; 1991 Jul; 125(1):14-7. PubMed ID: 1873196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relevance of histamine and tryptase concentrations in nasal secretions after nasal challenges with phosphate buffered saline and allergen.
    Wang D; Clement P; Smitz J; Derde MP
    Mediators Inflamm; 1995; 4(2):98-102. PubMed ID: 18475623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allergen-mediated histamine release from whole blood. Clinical evaluation.
    Radermecker MF
    Int Arch Allergy Appl Immunol; 1980; 63(4):415-23. PubMed ID: 6159331
    [No Abstract]   [Full Text] [Related]  

  • 45. Severe reaction to vancomycin not mediated by histamine release and documented by rechallenge.
    Sahai JV; Polk RE; Schwartz LB; Healy DP; Westin EH
    J Infect Dis; 1988 Dec; 158(6):1413-4. PubMed ID: 2461997
    [No Abstract]   [Full Text] [Related]  

  • 46. Histamine as possible chemical mediator for cutaneous pain. Dual pain response to histamine.
    ROSENTHAL SR
    Proc Soc Exp Biol Med; 1950 May; 74(1):167-70. PubMed ID: 15430422
    [No Abstract]   [Full Text] [Related]  

  • 47. Fight over ag research continues.
    Fox JL
    Science; 1984 Jul; 225(4658):151. PubMed ID: 17837917
    [No Abstract]   [Full Text] [Related]  

  • 48. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients.
    Nittner-Marszalska M; Cichocka-Jarosz E; Sanak M; Wujczyk M; Dor-Wojnarowska A; Lis G; Liebhart J
    Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):317-25. PubMed ID: 25763689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mast cell proteases as protective and inflammatory mediators.
    Caughey GH
    Adv Exp Med Biol; 2011; 716():212-34. PubMed ID: 21713659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.
    McILwain RB; Timpa JG; Kurundkar AR; Holt DW; Kelly DR; Hartman YE; Neel ML; Karnatak RK; Schelonka RL; Anantharamaiah GM; Killingsworth CR; Maheshwari A
    Lab Invest; 2010 Jan; 90(1):128-39. PubMed ID: 19901912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of inflammatory events during developing immunoglobulin E-mediated late-phase reactions and delayed-hypersensitivity reactions.
    Zweiman B; Moskovitz AR; von Allmen C
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):574-7. PubMed ID: 9665969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Connective tissue mast cells exhibit time-dependent degranulation heterogeneity.
    Kaminer MS; Murphy GF; Zweiman B; Lavker RM
    Clin Diagn Lab Immunol; 1995 May; 2(3):297-301. PubMed ID: 7664175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine.
    Michel L; Murrieta-Aguttes M; Jean-Louis F; Levy D; Dubertret L
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):64-9. PubMed ID: 10923607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma.
    Wenzel SE; Fowler AA; Schwartz LB
    Am Rev Respir Dis; 1988 May; 137(5):1002-8. PubMed ID: 2461667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo antigen-induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administration.
    Atkins PC; Schwartz LB; Adkinson NF; von Allmen C; Valenzano M; Zweiman B
    J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):360-70. PubMed ID: 1698845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of basophils in allergic disease.
    Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Release of histamine and tryptase in vivo after prolonged cutaneous challenge with allergen in humans.
    Shalit M; Schwartz LB; Golzar N; vonAllman C; Valenzano M; Fleekop P; Atkins PC; Zweiman B
    J Immunol; 1988 Aug; 141(3):821-6. PubMed ID: 2456334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Release of histamine and tryptase during continuous and interrupted cutaneous challenge with allergen in humans.
    Shalit M; Schwartz LB; von Allmen C; Atkins PC; Lavker RM; Zweiman B
    J Allergy Clin Immunol; 1990 Jul; 86(1):117-25. PubMed ID: 1695232
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.